Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/ db and DIO mice

Fibroblast growth factor 21 (FGF21) is an endocrine-acting hormone that has the potential to treat diabetic nephropathy. However, development of FGF21 into a therapeutic has been hindered due to its low intrinsic bio-stability.